APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-lethal Biochemical Weapons

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non-lethal Biochemical Weapons Market Analysis and Forecast 2026-2032

5 January 2026214 pages

Choose your research edition.

Industry ResearchNon-lethal Biochemical Weapons Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-lethal Biochemical Weapons Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Non-lethal Biochemical Weapons Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-lethal Biochemical Weapons Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-lethal Biochemical Weapons Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Non-lethal Biochemical Weapons market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Non-lethal Biochemical Weapons's global sales reached XX (k units) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Lamperd Less Lethal as the global sales leader, a title it has maintained for several consecutive years. Notably, Lamperd Less Lethal's performance in primary markets is also remarkable. In the Chinese market, sales were XX (k units), a change of XX% from the previous year. In Europe, sales were XX (k units), showing a year-on-year of XX%. In the US, sales were XX (k units), a year-on-year change of XX%.

The major global manufacturers in the Non-lethal Biochemical Weapons market include Lamperd Less Lethal, BAE Systems, Inc., QinetiqGroup, Inc., General Dynamics Corporation, TASER International,Inc., Moog, Inc., Raytheon Company, Chemring Group PLC. and Textron Systems, Corp, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Non-lethal Biochemical Weapons production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Non-lethal Biochemical Weapons by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Non-lethal Biochemical Weapons, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-lethal Biochemical Weapons, also provides the consumption of main regions and countries. Of the upcoming market potential for Non-lethal Biochemical Weapons, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-lethal Biochemical Weapons sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-lethal Biochemical Weapons market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Non-lethal Biochemical Weapons sales, projected growth trends, production technology, application and end-user industry.

Non-lethal Biochemical Weapons Segment by Company

Lamperd Less Lethal

BAE Systems, Inc.

QinetiqGroup, Inc.

General Dynamics Corporation

TASER International,Inc.

Moog, Inc.

Raytheon Company

Chemring Group PLC.

Textron Systems, Corp

LRAD Corporation

Non-lethal Biochemical Weapons Segment by Type

Directed Energy

Direct Contact

Non-lethal Biochemical Weapons Segment by Application

Military Forces

Law Enforcement Agencies

Non-lethal Biochemical Weapons Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-lethal Biochemical Weapons market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-lethal Biochemical Weapons and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-lethal Biochemical Weapons.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Non-lethal Biochemical Weapons production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Non-lethal Biochemical Weapons in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Non-lethal Biochemical Weapons manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-lethal Biochemical Weapons sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-lethal Biochemical Weapons Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Directed Energy Major Manufacturers Table 3. Direct Contact Major Manufacturers Table 4. Global Non-lethal Biochemical Weapons Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Military Forces Major Manufacturers Table 6. Law Enforcement Agencies Major Manufacturers Table 7. Non-lethal Biochemical Weapons Industry Trends Table 8. Non-lethal Biochemical Weapons Industry Drivers Table 9. Non-lethal Biochemical Weapons Industry Opportunities and Challenges Table 10. Non-lethal Biochemical Weapons Industry Restraints Table 11. Global Non-lethal Biochemical Weapons Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 12. Global Non-lethal Biochemical Weapons Production by Region (2021-2026) & (k units) Table 13. Global Non-lethal Biochemical Weapons Production by Region (2027-2032) & (k units) Table 14. Global Non-lethal Biochemical Weapons Production Market Share by Region (2021-2026) Table 15. Global Non-lethal Biochemical Weapons Production Market Share by Region (2027-2032) Table 16. Global Non-lethal Biochemical Weapons Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Non-lethal Biochemical Weapons Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Non-lethal Biochemical Weapons Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Non-lethal Biochemical Weapons Revenue Market Share by Region (2021-2026) Table 20. Global Non-lethal Biochemical Weapons Revenue Market Share by Region (2027-2032) Table 21. Global Non-lethal Biochemical Weapons Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Non-lethal Biochemical Weapons Sales by Region (2021-2026) & (k units) Table 23. Global Non-lethal Biochemical Weapons Sales by Region (2027-2032) & (k units) Table 24. Global Non-lethal Biochemical Weapons Sales Market Share by Region (2021-2026) Table 25. Global Non-lethal Biochemical Weapons Sales Market Share by Region (2027-2032) Table 26. Global Non-lethal Biochemical Weapons Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Non-lethal Biochemical Weapons Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Non-lethal Biochemical Weapons Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Non-lethal Biochemical Weapons Sales Market Share by Manufacturers (2021-2026) Table 30. Global Non-lethal Biochemical Weapons Sales Price (USD/unit) of Manufacturers (2021-2026) Table 31. Global Non-lethal Biochemical Weapons Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Non-lethal Biochemical Weapons Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Non-lethal Biochemical Weapons Manufacturers, Product Type & Application Table 34. Global Non-lethal Biochemical Weapons Manufacturers Commercialization Time Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Non-lethal Biochemical Weapons by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 37. Global Non-lethal Biochemical Weapons Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Non-lethal Biochemical Weapons Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Non-lethal Biochemical Weapons Revenue Market Share by Type (2021-2026) Table 40. Global Non-lethal Biochemical Weapons Revenue Market Share by Type (2027-2032) Table 41. Global Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (k units) Table 42. Global Non-lethal Biochemical Weapons Sales by Type (2027-2032) & (k units) Table 43. Global Non-lethal Biochemical Weapons Sales Market Share by Type (2021-2026) Table 44. Global Non-lethal Biochemical Weapons Sales Market Share by Type (2027-2032) Table 45. Global Non-lethal Biochemical Weapons Price by Type (2021-2026) & (USD/unit) Table 46. Global Non-lethal Biochemical Weapons Price by Type (2027-2032) & (USD/unit) Table 47. Global Non-lethal Biochemical Weapons Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Non-lethal Biochemical Weapons Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Non-lethal Biochemical Weapons Revenue Market Share by Application (2021-2026) Table 50. Global Non-lethal Biochemical Weapons Revenue Market Share by Application (2027-2032) Table 51. Global Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (k units) Table 52. Global Non-lethal Biochemical Weapons Sales by Application (2027-2032) & (k units) Table 53. Global Non-lethal Biochemical Weapons Sales Market Share by Application (2021-2026) Table 54. Global Non-lethal Biochemical Weapons Sales Market Share by Application (2027-2032) Table 55. Global Non-lethal Biochemical Weapons Price by Application (2021-2026) & (USD/unit) Table 56. Global Non-lethal Biochemical Weapons Price by Application (2027-2032) & (USD/unit) Table 57. Lamperd Less Lethal Company Information Table 58. Lamperd Less Lethal Business Overview Table 59. Lamperd Less Lethal Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 60. Lamperd Less Lethal Non-lethal Biochemical Weapons Product Portfolio Table 61. Lamperd Less Lethal Recent Development Table 62. BAE Systems, Inc. Company Information Table 63. BAE Systems, Inc. Business Overview Table 64. BAE Systems, Inc. Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 65. BAE Systems, Inc. Non-lethal Biochemical Weapons Product Portfolio Table 66. BAE Systems, Inc. Recent Development Table 67. QinetiqGroup, Inc. Company Information Table 68. QinetiqGroup, Inc. Business Overview Table 69. QinetiqGroup, Inc. Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. QinetiqGroup, Inc. Non-lethal Biochemical Weapons Product Portfolio Table 71. QinetiqGroup, Inc. Recent Development Table 72. General Dynamics Corporation Company Information Table 73. General Dynamics Corporation Business Overview Table 74. General Dynamics Corporation Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. General Dynamics Corporation Non-lethal Biochemical Weapons Product Portfolio Table 76. General Dynamics Corporation Recent Development Table 77. TASER International,Inc. Company Information Table 78. TASER International,Inc. Business Overview Table 79. TASER International,Inc. Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. TASER International,Inc. Non-lethal Biochemical Weapons Product Portfolio Table 81. TASER International,Inc. Recent Development Table 82. Moog, Inc. Company Information Table 83. Moog, Inc. Business Overview Table 84. Moog, Inc. Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Moog, Inc. Non-lethal Biochemical Weapons Product Portfolio Table 86. Moog, Inc. Recent Development Table 87. Raytheon Company Company Information Table 88. Raytheon Company Business Overview Table 89. Raytheon Company Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Raytheon Company Non-lethal Biochemical Weapons Product Portfolio Table 91. Raytheon Company Recent Development Table 92. Chemring Group PLC. Company Information Table 93. Chemring Group PLC. Business Overview Table 94. Chemring Group PLC. Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Chemring Group PLC. Non-lethal Biochemical Weapons Product Portfolio Table 96. Chemring Group PLC. Recent Development Table 97. Textron Systems, Corp Company Information Table 98. Textron Systems, Corp Business Overview Table 99. Textron Systems, Corp Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Textron Systems, Corp Non-lethal Biochemical Weapons Product Portfolio Table 101. Textron Systems, Corp Recent Development Table 102. LRAD Corporation Company Information Table 103. LRAD Corporation Business Overview Table 104. LRAD Corporation Non-lethal Biochemical Weapons Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. LRAD Corporation Non-lethal Biochemical Weapons Product Portfolio Table 106. LRAD Corporation Recent Development Table 107. North America Non-lethal Biochemical Weapons Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Non-lethal Biochemical Weapons Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (k units) Table 110. North America Non-lethal Biochemical Weapons Sales by Type (2027-2032) & (k units) Table 111. North America Non-lethal Biochemical Weapons Sales Price by Type (2021-2026) & (USD/unit) Table 112. North America Non-lethal Biochemical Weapons Sales Price by Type (2027-2032) & (USD/unit) Table 113. North America Non-lethal Biochemical Weapons Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Non-lethal Biochemical Weapons Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (k units) Table 116. North America Non-lethal Biochemical Weapons Sales by Application (2027-2032) & (k units) Table 117. North America Non-lethal Biochemical Weapons Sales Price by Application (2021-2026) & (USD/unit) Table 118. North America Non-lethal Biochemical Weapons Sales Price by Application (2027-2032) & (USD/unit) Table 119. North America Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Non-lethal Biochemical Weapons Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 123. North America Non-lethal Biochemical Weapons Sales by Country (2021-2026) & (k units) Table 124. North America Non-lethal Biochemical Weapons Sales by Country (2027-2032) & (k units) Table 125. North America Non-lethal Biochemical Weapons Sales Price by Country (2021-2026) & (USD/unit) Table 126. North America Non-lethal Biochemical Weapons Sales Price by Country (2027-2032) & (USD/unit) Table 127. United States Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 128. Canada Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 129. Mexico Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 130. Europe Non-lethal Biochemical Weapons Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Non-lethal Biochemical Weapons Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (k units) Table 133. Europe Non-lethal Biochemical Weapons Sales by Type (2027-2032) & (k units) Table 134. Europe Non-lethal Biochemical Weapons Sales Price by Type (2021-2026) & (USD/unit) Table 135. Europe Non-lethal Biochemical Weapons Sales Price by Type (2027-2032) & (USD/unit) Table 136. Europe Non-lethal Biochemical Weapons Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Non-lethal Biochemical Weapons Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (k units) Table 139. Europe Non-lethal Biochemical Weapons Sales by Application (2027-2032) & (k units) Table 140. Europe Non-lethal Biochemical Weapons Sales Price by Application (2021-2026) & (USD/unit) Table 141. Europe Non-lethal Biochemical Weapons Sales Price by Application (2027-2032) & (USD/unit) Table 142. Europe Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe Non-lethal Biochemical Weapons Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 146. Europe Non-lethal Biochemical Weapons Sales by Country (2021-2026) & (k units) Table 147. Europe Non-lethal Biochemical Weapons Sales by Country (2027-2032) & (k units) Table 148. Europe Non-lethal Biochemical Weapons Sales Price by Country (2021-2026) & (USD/unit) Table 149. Europe Non-lethal Biochemical Weapons Sales Price by Country (2027-2032) & (USD/unit) Table 150. Germany Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 151. France Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 152. U.K. Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 153. Italy Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 154. Russia Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 155. Spain Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 156. Netherlands Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 157. Switzerland Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 158. Sweden Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 159. Poland Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 160. China Non-lethal Biochemical Weapons Revenue by Type (2021-2026) & (US$ Million) Table 161. China Non-lethal Biochemical Weapons Revenue by Type (2027-2032) & (US$ Million) Table 162. China Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (k units) Table 163. China Non-lethal Biochemical Weapons Sales by Type (2027-2032) & (k units) Table 164. China Non-lethal Biochemical Weapons Sales Price by Type (2021-2026) & (USD/unit) Table 165. China Non-lethal Biochemical Weapons Sales Price by Type (2027-2032) & (USD/unit) Table 166. China Non-lethal Biochemical Weapons Revenue by Application (2021-2026) & (US$ Million) Table 167. China Non-lethal Biochemical Weapons Revenue by Application (2027-2032) & (US$ Million) Table 168. China Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (k units) Table 169. China Non-lethal Biochemical Weapons Sales by Application (2027-2032) & (k units) Table 170. China Non-lethal Biochemical Weapons Sales Price by Application (2021-2026) & (USD/unit) Table 171. China Non-lethal Biochemical Weapons Sales Price by Application (2027-2032) & (USD/unit) Table 172. Asia Non-lethal Biochemical Weapons Revenue by Type (2021-2026) & (US$ Million) Table 173. Asia Non-lethal Biochemical Weapons Revenue by Type (2027-2032) & (US$ Million) Table 174. Asia Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (k units) Table 175. Asia Non-lethal Biochemical Weapons Sales by Type (2027-2032) & (k units) Table 176. Asia Non-lethal Biochemical Weapons Sales Price by Type (2021-2026) & (USD/unit) Table 177. Asia Non-lethal Biochemical Weapons Sales Price by Type (2027-2032) & (USD/unit) Table 178. Asia Non-lethal Biochemical Weapons Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Non-lethal Biochemical Weapons Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (k units) Table 181. Asia Non-lethal Biochemical Weapons Sales by Application (2027-2032) & (k units) Table 182. Asia Non-lethal Biochemical Weapons Sales Price by Application (2021-2026) & (USD/unit) Table 183. Asia Non-lethal Biochemical Weapons Sales Price by Application (2027-2032) & (USD/unit) Table 184. Asia Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Asia Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Asia Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Asia Non-lethal Biochemical Weapons Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 188. Asia Non-lethal Biochemical Weapons Sales by Country (2021-2026) & (k units) Table 189. Asia Non-lethal Biochemical Weapons Sales by Country (2027-2032) & (k units) Table 190. Asia Non-lethal Biochemical Weapons Sales Price by Country (2021-2026) & (USD/unit) Table 191. Asia Non-lethal Biochemical Weapons Sales Price by Country (2027-2032) & (USD/unit) Table 192. Japan Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 193. South Korea Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 194. India Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 195. Australia Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 196. Taiwan Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 197. Southeast Asia Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 198. SAMEA Non-lethal Biochemical Weapons Revenue by Type (2021-2026) & (US$ Million) Table 199. SAMEA Non-lethal Biochemical Weapons Revenue by Type (2027-2032) & (US$ Million) Table 200. SAMEA Non-lethal Biochemical Weapons Sales by Type (2021-2026) & (k units) Table 201. SAMEA Non-lethal Biochemical Weapons Sales by Type (2027-2032) & (k units) Table 202. SAMEA Non-lethal Biochemical Weapons Sales Price by Type (2021-2026) & (USD/unit) Table 203. SAMEA Non-lethal Biochemical Weapons Sales Price by Type (2027-2032) & (USD/unit) Table 204. SAMEA Non-lethal Biochemical Weapons Revenue by Application (2021-2026) & (US$ Million) Table 205. SAMEA Non-lethal Biochemical Weapons Revenue by Application (2027-2032) & (US$ Million) Table 206. SAMEA Non-lethal Biochemical Weapons Sales by Application (2021-2026) & (k units) Table 207. SAMEA Non-lethal Biochemical Weapons Sales by Application (2027-2032) & (k units) Table 208. SAMEA Non-lethal Biochemical Weapons Sales Price by Application (2021-2026) & (USD/unit) Table 209. SAMEA Non-lethal Biochemical Weapons Sales Price by Application (2027-2032) & (USD/unit) Table 210. SAMEA Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. SAMEA Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. SAMEA Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. SAMEA Non-lethal Biochemical Weapons Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 214. SAMEA Non-lethal Biochemical Weapons Sales by Country (2021-2026) & (k units) Table 215. SAMEA Non-lethal Biochemical Weapons Sales by Country (2027-2032) & (k units) Table 216. SAMEA Non-lethal Biochemical Weapons Sales Price by Country (2021-2026) & (USD/unit) Table 217. SAMEA Non-lethal Biochemical Weapons Sales Price by Country (2027-2032) & (USD/unit) Table 218. Brazil Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 219. Argentina Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 220. Chile Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 221. Colombia Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 222. Peru Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 223. Saudi Arabia Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 224. Israel Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 225. UAE Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 226. Turkey Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 227. Iran Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 228. Egypt Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Table 229. Key Raw Materials Table 230. Raw Materials Key Suppliers Table 231. Non-lethal Biochemical Weapons Distributors List Table 232. Non-lethal Biochemical Weapons Customers List Table 233. Research Programs/Design for This Report Table 234. Authors List of This Report Table 235. Secondary Sources Table 236. Primary Sources List of Figures Figure 1. Non-lethal Biochemical Weapons Product Image Figure 2. Global Non-lethal Biochemical Weapons Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-lethal Biochemical Weapons Market Size Share 2021 VS 2025 VS 2032 Figure . Directed Energy Image Figure 1. Direct Contact Image Figure 2. Global Non-lethal Biochemical Weapons Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-lethal Biochemical Weapons Market Size Share 2021 VS 2025 VS 2032 Figure 4. Military Forces Image Figure 5. Law Enforcement Agencies Image Figure 6. Global Non-lethal Biochemical Weapons Capacity, Capacity Utilization (2021-2032) & (k units) Figure 7. Global Non-lethal Biochemical Weapons Production by Region: 2021 VS 2025 VS 2032 (k units) Figure 8. Global Non-lethal Biochemical Weapons Production Market Share by Region: 2025 Versus 2032 Figure 9. Global Non-lethal Biochemical Weapons Production Market Share by Region (2021-2032) Figure 10. North America Non-lethal Biochemical Weapons Production Growth Rate (2021-2032) & (k units) Figure 11. Europe Non-lethal Biochemical Weapons Production Growth Rate (2021-2032) & (k units) Figure 12. China Non-lethal Biochemical Weapons Production Growth Rate (2021-2032) & (k units) Figure 13. Japan Non-lethal Biochemical Weapons Production Growth Rate (2021-2032) & (k units) Figure 14. South Korea Non-lethal Biochemical Weapons Production Growth Rate (2021-2032) & (k units) Figure 15. India Non-lethal Biochemical Weapons Production Growth Rate (2021-2032) & (k units) Figure 16. Global Non-lethal Biochemical Weapons Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Non-lethal Biochemical Weapons Revenue (2021-2032) & (US$ Million) Figure 18. Global Non-lethal Biochemical Weapons Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Non-lethal Biochemical Weapons Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Non-lethal Biochemical Weapons Revenue Market Share by Region (2021-2032) Figure 21. Global Non-lethal Biochemical Weapons Sales (2021-2032) & (k units) Figure 22. Global Non-lethal Biochemical Weapons Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 23. Global Non-lethal Biochemical Weapons Sales Market Share by Region (2021-2032) Figure 24. North America Non-lethal Biochemical Weapons Sales YoY (2021-2032) & (k units) Figure 25. Europe Non-lethal Biochemical Weapons Sales YoY (2021-2032) & (k units) Figure 26. China Non-lethal Biochemical Weapons Sales YoY (2021-2032) & (k units) Figure 27. Asia (Excluding China) Non-lethal Biochemical Weapons Sales YoY (2021-2032) & (k units) Figure 28. South America, Middle East and Africa Non-lethal Biochemical Weapons Sales YoY (2021-2032) & (k units) Figure 29. Global Non-lethal Biochemical Weapons Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Non-lethal Biochemical Weapons Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Non-lethal Biochemical Weapons Revenue Market Share by Type (2021-2032) Figure 33. Global Non-lethal Biochemical Weapons Sales Market Share by Type (2021-2032) Figure 34. Global Non-lethal Biochemical Weapons Revenue Market Share by Application (2021-2032) Figure 35. Global Non-lethal Biochemical Weapons Sales Market Share by Application (2021-2032) Figure 36. North America Non-lethal Biochemical Weapons Revenue Share by Type (2021-2032) Figure 37. North America Non-lethal Biochemical Weapons Sales Share by Type (2021-2032) Figure 38. North America Non-lethal Biochemical Weapons Revenue Share by Application (2021-2032) Figure 39. North America Non-lethal Biochemical Weapons Sales Share by Application (2021-2032) Figure 40. North America Non-lethal Biochemical Weapons Revenue Share by Country (2021-2032) Figure 41. North America Non-lethal Biochemical Weapons Sales Share by Country (2021-2032) Figure 42. Europe Non-lethal Biochemical Weapons Revenue Share by Type (2021-2032) Figure 43. Europe Non-lethal Biochemical Weapons Sales Share by Type (2021-2032) Figure 44. Europe Non-lethal Biochemical Weapons Revenue Share by Application (2021-2032) Figure 45. Europe Non-lethal Biochemical Weapons Sales Share by Application (2021-2032) Figure 46. Europe Non-lethal Biochemical Weapons Revenue Share by Country (2021-2032) Figure 47. Europe Non-lethal Biochemical Weapons Sales Share by Country (2021-2032) Figure 48. China Non-lethal Biochemical Weapons Revenue Share by Type (2021-2032) Figure 49. China Non-lethal Biochemical Weapons Sales Share by Type (2021-2032) Figure 50. China Non-lethal Biochemical Weapons Revenue Share by Application (2021-2032) Figure 51. China Non-lethal Biochemical Weapons Sales Share by Application (2021-2032) Figure 52. Asia Non-lethal Biochemical Weapons Revenue Share by Type (2021-2032) Figure 53. Asia Non-lethal Biochemical Weapons Sales Share by Type (2021-2032) Figure 54. Asia Non-lethal Biochemical Weapons Revenue Share by Application (2021-2032) Figure 55. Asia Non-lethal Biochemical Weapons Sales Share by Application (2021-2032) Figure 56. Asia Non-lethal Biochemical Weapons Revenue Share by Country (2021-2032) Figure 57. Asia Non-lethal Biochemical Weapons Sales Share by Country (2021-2032) Figure 58. SAMEA Non-lethal Biochemical Weapons Revenue Share by Type (2021-2032) Figure 59. SAMEA Non-lethal Biochemical Weapons Sales Share by Type (2021-2032) Figure 60. SAMEA Non-lethal Biochemical Weapons Revenue Share by Application (2021-2032) Figure 61. SAMEA Non-lethal Biochemical Weapons Sales Share by Application (2021-2032) Figure 62. SAMEA Non-lethal Biochemical Weapons Revenue Share by Country (2021-2032) Figure 63. SAMEA Non-lethal Biochemical Weapons Sales Share by Country (2021-2032) Figure 64. Non-lethal Biochemical Weapons Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Non-lethal Biochemical Weapons Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Directed Energy
  • Direct Contact
Applications
  • Military Forces
  • Law Enforcement Agencies
Companies covered
  • Lamperd Less Lethal
  • BAE Systems, Inc.
  • QinetiqGroup, Inc.
  • General Dynamics Corporation
  • TASER International,Inc.
  • Moog, Inc.
  • Raytheon Company
  • Chemring Group PLC.
  • Textron Systems, Corp
  • LRAD Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-lethal Biochemical Weapons Market by Type
  3. 1.2.1 Global Non-lethal Biochemical Weapons Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Directed Energy
  5. 1.2.3 Direct Contact
  6. 1.3 Non-lethal Biochemical Weapons Market by Application
  7. 1.3.1 Global Non-lethal Biochemical Weapons Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Military Forces
  9. 1.3.3 Law Enforcement Agencies
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Non-lethal Biochemical Weapons Market Dynamics
  1. 2.1 Non-lethal Biochemical Weapons Industry Trends
  2. 2.2 Non-lethal Biochemical Weapons Industry Drivers
  3. 2.3 Non-lethal Biochemical Weapons Industry Opportunities and Challenges
  4. 2.4 Non-lethal Biochemical Weapons Industry Restraints
3 Global Non-lethal Biochemical Weapons Production Overview
  1. 3.1 Global Non-lethal Biochemical Weapons Production Capacity (2021-2032)
  2. 3.2 Global Non-lethal Biochemical Weapons Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Non-lethal Biochemical Weapons Production by Region
  4. 3.3.1 Global Non-lethal Biochemical Weapons Production by Region (2021-2026)
  5. 3.3.2 Global Non-lethal Biochemical Weapons Production by Region (2027-2032)
  6. 3.3.3 Global Non-lethal Biochemical Weapons Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
  11. 3.8 South Korea
  12. 3.9 India
4 Global Market Growth Prospects
  1. 4.1 Global Non-lethal Biochemical Weapons Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Non-lethal Biochemical Weapons Revenue by Region
  3. 4.2.1 Global Non-lethal Biochemical Weapons Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Non-lethal Biochemical Weapons Revenue by Region (2021-2026)
  5. 4.2.3 Global Non-lethal Biochemical Weapons Revenue by Region (2027-2032)
  6. 4.2.4 Global Non-lethal Biochemical Weapons Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Non-lethal Biochemical Weapons Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Non-lethal Biochemical Weapons Sales by Region
  9. 4.4.1 Global Non-lethal Biochemical Weapons Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Non-lethal Biochemical Weapons Sales by Region (2021-2026)
  11. 4.4.3 Global Non-lethal Biochemical Weapons Sales by Region (2027-2032)
  12. 4.4.4 Global Non-lethal Biochemical Weapons Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Non-lethal Biochemical Weapons Revenue by Manufacturers
  2. 5.1.1 Global Non-lethal Biochemical Weapons Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Non-lethal Biochemical Weapons Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Non-lethal Biochemical Weapons Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Non-lethal Biochemical Weapons Sales by Manufacturers
  6. 5.2.1 Global Non-lethal Biochemical Weapons Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Non-lethal Biochemical Weapons Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Non-lethal Biochemical Weapons Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Non-lethal Biochemical Weapons Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Non-lethal Biochemical Weapons Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Non-lethal Biochemical Weapons Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Non-lethal Biochemical Weapons Manufacturers, Product Type & Application
  13. 5.7 Global Non-lethal Biochemical Weapons Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Non-lethal Biochemical Weapons Market CR5 and HHI
  16. 5.8.2 2025 Non-lethal Biochemical Weapons Tier 1, Tier 2, and Tier 3
6 Non-lethal Biochemical Weapons Market by Type
  1. 6.1 Global Non-lethal Biochemical Weapons Revenue by Type
  2. 6.1.1 Global Non-lethal Biochemical Weapons Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Non-lethal Biochemical Weapons Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Non-lethal Biochemical Weapons Sales by Type
  5. 6.2.1 Global Non-lethal Biochemical Weapons Sales by Type (2021-2032) & (k units)
  6. 6.2.2 Global Non-lethal Biochemical Weapons Sales Market Share by Type (2021-2032)
  7. 6.3 Global Non-lethal Biochemical Weapons Price by Type
7 Non-lethal Biochemical Weapons Market by Application
  1. 7.1 Global Non-lethal Biochemical Weapons Revenue by Application
  2. 7.1.1 Global Non-lethal Biochemical Weapons Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Non-lethal Biochemical Weapons Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Non-lethal Biochemical Weapons Sales by Application
  5. 7.2.1 Global Non-lethal Biochemical Weapons Sales by Application (2021-2032) & (k units)
  6. 7.2.2 Global Non-lethal Biochemical Weapons Sales Market Share by Application (2021-2032)
  7. 7.3 Global Non-lethal Biochemical Weapons Price by Application
8 Company Profiles
  1. 8.1 Lamperd Less Lethal
  2. 8.1.1 Lamperd Less Lethal Company Information
  3. 8.1.2 Lamperd Less Lethal Business Overview
  4. 8.1.3 Lamperd Less Lethal Non-lethal Biochemical Weapons Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Lamperd Less Lethal Non-lethal Biochemical Weapons Product Portfolio
  6. 8.1.5 Lamperd Less Lethal Recent Developments
  7. 8.2 BAE Systems, Inc.
  8. 8.2.1 BAE Systems, Inc. Company Information
  9. 8.2.2 BAE Systems, Inc. Business Overview
  10. 8.2.3 BAE Systems, Inc. Non-lethal Biochemical Weapons Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 BAE Systems, Inc. Non-lethal Biochemical Weapons Product Portfolio
  12. 8.2.5 BAE Systems, Inc. Recent Developments
  13. 8.3 QinetiqGroup, Inc.
  14. 8.3.1 QinetiqGroup, Inc. Company Information
  15. 8.3.2 QinetiqGroup, Inc. Business Overview
  16. 8.3.3 QinetiqGroup, Inc. Non-lethal Biochemical Weapons Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 QinetiqGroup, Inc. Non-lethal Biochemical Weapons Product Portfolio
  18. 8.3.5 QinetiqGroup, Inc. Recent Developments
  19. 8.4 General Dynamics Corporation
  20. 8.4.1 General Dynamics Corporation Company Information
  21. 8.4.2 General Dynamics Corporation Business Overview
  22. 8.4.3 General Dynamics Corporation Non-lethal Biochemical Weapons Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 General Dynamics Corporation Non-lethal Biochemical Weapons Product Portfolio
  24. 8.4.5 General Dynamics Corporation Recent Developments
  25. 8.5 TASER International,Inc.
  26. 8.5.1 TASER International,Inc. Company Information
  27. 8.5.2 TASER International,Inc. Business Overview
  28. 8.5.3 TASER International,Inc. Non-lethal Biochemical Weapons Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 TASER International,Inc. Non-lethal Biochemical Weapons Product Portfolio
  30. 8.5.5 TASER International,Inc. Recent Developments
  31. 8.6 Moog, Inc.
  32. 8.6.1 Moog, Inc. Company Information
  33. 8.6.2 Moog, Inc. Business Overview
  34. 8.6.3 Moog, Inc. Non-lethal Biochemical Weapons Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Moog, Inc. Non-lethal Biochemical Weapons Product Portfolio
  36. 8.6.5 Moog, Inc. Recent Developments
  37. 8.7 Raytheon Company
  38. 8.7.1 Raytheon Company Company Information
  39. 8.7.2 Raytheon Company Business Overview
  40. 8.7.3 Raytheon Company Non-lethal Biochemical Weapons Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Raytheon Company Non-lethal Biochemical Weapons Product Portfolio
  42. 8.7.5 Raytheon Company Recent Developments
  43. 8.8 Chemring Group PLC.
  44. 8.8.1 Chemring Group PLC. Company Information
  45. 8.8.2 Chemring Group PLC. Business Overview
  46. 8.8.3 Chemring Group PLC. Non-lethal Biochemical Weapons Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Chemring Group PLC. Non-lethal Biochemical Weapons Product Portfolio
  48. 8.8.5 Chemring Group PLC. Recent Developments
  49. 8.9 Textron Systems, Corp
  50. 8.9.1 Textron Systems, Corp Company Information
  51. 8.9.2 Textron Systems, Corp Business Overview
  52. 8.9.3 Textron Systems, Corp Non-lethal Biochemical Weapons Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Textron Systems, Corp Non-lethal Biochemical Weapons Product Portfolio
  54. 8.9.5 Textron Systems, Corp Recent Developments
  55. 8.10 LRAD Corporation
  56. 8.10.1 LRAD Corporation Company Information
  57. 8.10.2 LRAD Corporation Business Overview
  58. 8.10.3 LRAD Corporation Non-lethal Biochemical Weapons Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 LRAD Corporation Non-lethal Biochemical Weapons Product Portfolio
  60. 8.10.5 LRAD Corporation Recent Developments
9 North America
  1. 9.1 North America Non-lethal Biochemical Weapons Market Size by Type
  2. 9.1.1 North America Non-lethal Biochemical Weapons Revenue by Type (2021-2032)
  3. 9.1.2 North America Non-lethal Biochemical Weapons Sales by Type (2021-2032)
  4. 9.1.3 North America Non-lethal Biochemical Weapons Price by Type (2021-2032)
  5. 9.2 North America Non-lethal Biochemical Weapons Market Size by Application
  6. 9.2.1 North America Non-lethal Biochemical Weapons Revenue by Application (2021-2032)
  7. 9.2.2 North America Non-lethal Biochemical Weapons Sales by Application (2021-2032)
  8. 9.2.3 North America Non-lethal Biochemical Weapons Price by Application (2021-2032)
  9. 9.3 North America Non-lethal Biochemical Weapons Market Size by Country
  10. 9.3.1 North America Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Non-lethal Biochemical Weapons Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Non-lethal Biochemical Weapons Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Non-lethal Biochemical Weapons Market Size by Type
  2. 10.1.1 Europe Non-lethal Biochemical Weapons Revenue by Type (2021-2032)
  3. 10.1.2 Europe Non-lethal Biochemical Weapons Sales by Type (2021-2032)
  4. 10.1.3 Europe Non-lethal Biochemical Weapons Price by Type (2021-2032)
  5. 10.2 Europe Non-lethal Biochemical Weapons Market Size by Application
  6. 10.2.1 Europe Non-lethal Biochemical Weapons Revenue by Application (2021-2032)
  7. 10.2.2 Europe Non-lethal Biochemical Weapons Sales by Application (2021-2032)
  8. 10.2.3 Europe Non-lethal Biochemical Weapons Price by Application (2021-2032)
  9. 10.3 Europe Non-lethal Biochemical Weapons Market Size by Country
  10. 10.3.1 Europe Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Non-lethal Biochemical Weapons Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Non-lethal Biochemical Weapons Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Non-lethal Biochemical Weapons Market Size by Type
  2. 11.1.1 China Non-lethal Biochemical Weapons Revenue by Type (2021-2032)
  3. 11.1.2 China Non-lethal Biochemical Weapons Sales by Type (2021-2032)
  4. 11.1.3 China Non-lethal Biochemical Weapons Price by Type (2021-2032)
  5. 11.2 China Non-lethal Biochemical Weapons Market Size by Application
  6. 11.2.1 China Non-lethal Biochemical Weapons Revenue by Application (2021-2032)
  7. 11.2.2 China Non-lethal Biochemical Weapons Sales by Application (2021-2032)
  8. 11.2.3 China Non-lethal Biochemical Weapons Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Non-lethal Biochemical Weapons Market Size by Type
  2. 12.1.1 Asia Non-lethal Biochemical Weapons Revenue by Type (2021-2032)
  3. 12.1.2 Asia Non-lethal Biochemical Weapons Sales by Type (2021-2032)
  4. 12.1.3 Asia Non-lethal Biochemical Weapons Price by Type (2021-2032)
  5. 12.2 Asia Non-lethal Biochemical Weapons Market Size by Application
  6. 12.2.1 Asia Non-lethal Biochemical Weapons Revenue by Application (2021-2032)
  7. 12.2.2 Asia Non-lethal Biochemical Weapons Sales by Application (2021-2032)
  8. 12.2.3 Asia Non-lethal Biochemical Weapons Price by Application (2021-2032)
  9. 12.3 Asia Non-lethal Biochemical Weapons Market Size by Country
  10. 12.3.1 Asia Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Non-lethal Biochemical Weapons Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Non-lethal Biochemical Weapons Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Non-lethal Biochemical Weapons Market Size by Type
  2. 13.1.1 SAMEA Non-lethal Biochemical Weapons Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Non-lethal Biochemical Weapons Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Non-lethal Biochemical Weapons Price by Type (2021-2032)
  5. 13.2 SAMEA Non-lethal Biochemical Weapons Market Size by Application
  6. 13.2.1 SAMEA Non-lethal Biochemical Weapons Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Non-lethal Biochemical Weapons Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Non-lethal Biochemical Weapons Price by Application (2021-2032)
  9. 13.3 SAMEA Non-lethal Biochemical Weapons Market Size by Country
  10. 13.3.1 SAMEA Non-lethal Biochemical Weapons Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Non-lethal Biochemical Weapons Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Non-lethal Biochemical Weapons Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Non-lethal Biochemical Weapons Value Chain Analysis
  2. 14.1.1 Non-lethal Biochemical Weapons Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Non-lethal Biochemical Weapons Production Mode & Process
  6. 14.2 Non-lethal Biochemical Weapons Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Non-lethal Biochemical Weapons Distributors
  9. 14.2.3 Non-lethal Biochemical Weapons Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst